Skip to main content
SpringerLink
Log in

Chronic Fatigue Syndrome

Psychotropic or Immunological Therapy?

  • Review Article
  • Drug Therapy
  • Published:
CNS Drugs Aims and scope Submit manuscript

Summary

Chronic fatigue syndrome (CFS) is an illness characterised by incapacitating fatigue and a pattern of somatic complaints without known cause. It is a controversial illness in that symptoms are subjective and overlap with symptoms of primary emotional disturbance.

The natural history of this illness is often characterised by spontaneous improvement, and a significant placebo response is frequently present. Therefore, results from poorly controlled trials may be misleading. Few adequate treatment trials have been done in patients with CFS, due to difficulties in case definition and the lack of definitive biological markers. However, numerous treatment regimens have been proposed over the last 30 years, the majority emphasising either psychotropic, immunological or antimicrobial therapy. While no single agent has been curative, benefit has been claimed for many agents. These include tricyclic antidepressants, the selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors fluoxetine and sertraline, amfebutamone (bupropion), immunoglobulin G, mismatched double-stranded RNA [Poly(I):Poly(C12U); ‘ampligen’] and essential fatty acids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Inf Dis 1991; 13 Suppl. 1: S9–12

    Google Scholar 

  2. Krupp LB, Mendelson WB, Friedman R. An overview of chronic fatigue syndrome. J Clin Psychiatry 1991; 52: 403–10

    PubMed  CAS  Google Scholar 

  3. Shafran S. The chronic fatigue syndrome. Am J Med 1991, 90: 730–9

    PubMed  CAS  Google Scholar 

  4. Bell DS. Chronic fatigue syndrome: recent advances in diagnosis and treatment. Postgrad Med 1992; 91: 245–52

    PubMed  CAS  Google Scholar 

  5. Henderson DA, Shelokov A. Epidemic neuromyasthenia-clinical syndrome. N Eng J Med 1959; 260: 757–64

    Article  CAS  Google Scholar 

  6. Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease, and epidemic neuromyasthenia. Am J Med 1959; 26: 569–95

    Article  PubMed  CAS  Google Scholar 

  7. Holmes GP, Kaplan JE, Stewart JA, et al. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA 1987; 257: 2297–302

    Article  PubMed  CAS  Google Scholar 

  8. Bell EJ, McCartney RA, Riding MH. Coxsackie B viruses and myalgic encephalomyelitis. J R Soc Med 1988; 81: 329

    PubMed  CAS  Google Scholar 

  9. Daugherty SA, Henry BE, Peterson DL, et al. Chronic fatigue syndrome in northern Nevada. Rev Inf Dis 1991; 13 Suppl 1.: S39–44

    Article  Google Scholar 

  10. Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in the chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–10

    PubMed  CAS  Google Scholar 

  11. Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139: 3306–13

    PubMed  CAS  Google Scholar 

  12. Gupta S, Vayuvegula B. Comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 33: 319–27

    Article  PubMed  CAS  Google Scholar 

  13. Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome:- clinical condition associated with immune activation. Lancet 1991; 338: 707–12

    Article  PubMed  CAS  Google Scholar 

  14. Abbey S, Garfinkel PE. Neurasthenia and chronic fatigue syndrome: the role of culture in making of a diagnosis. Am J Psychiatry 1991; 148: 1638–46

    PubMed  CAS  Google Scholar 

  15. Kruesi MJP, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry 1989; 50: 253–6

    Google Scholar 

  16. Lane TJ, Manu P, Matthews DA. Depression and somatization in the chronic fatigue syndrome. Am J Med 1991; 91: 335–44

    Article  PubMed  CAS  Google Scholar 

  17. Hickie I, Lloyd A, Wakefield D. Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome. Aust NZ J Psychiatry 1992; 26: 249–56

    Article  CAS  Google Scholar 

  18. Lloyd A, Hickie I, Hickie C, et al. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects, and patients with major depression. Clin Exp Immunol 1992; 87: 76–9

    Article  PubMed  CAS  Google Scholar 

  19. Klimas NG, Morgan R, Van Riel F, et al. Observations regarding use of an antidepressant, fluoxetine, in chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington DC: American Psychiatric Press, 1993: 95–108

    Google Scholar 

  20. Goodnick P, Sandoval R. Psychotropic treatment of chronic fatigue syndrome and related disorders. J Clin Psychiatry 1993; 54: 13–20

    PubMed  CAS  Google Scholar 

  21. Hench PK. Evaluation and differential diagnosis of fibromyalgia. Approach to diagnosis and management. Rheum Clin North Am 1989; 15: 19–29

    CAS  Google Scholar 

  22. Goldenberg DL. Fibromyalgia and other chronic fatigue syndromes: is there evidence for chronic viral disease? Sem Arthritis Rheum 1988; 18: 111–20

    Article  CAS  Google Scholar 

  23. Wysenbeek J, Mor F, Lurie Y, et al. Imipramine for the treatment of fibrositis: a therapeutic trial. Ann Rheum Dis 1985; 44: 752–3

    Article  PubMed  CAS  Google Scholar 

  24. Carette S, McCain GA, Bell DA. Evaluation of amitriptyline in primary fibrositis. Arthritis Rheum 1986; 29: 655–9

    Article  PubMed  CAS  Google Scholar 

  25. Goldenberg DL, Felson DT, Dinerman H. A randomized trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371–7

    Article  PubMed  CAS  Google Scholar 

  26. Scudds RA, McCain GA, Rollman GB, et al. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989; 16 Suppl.: S98–103

    Google Scholar 

  27. Jones JF. Chronic Epstein-Barr virus infection. Ann Rev Med 1987; 38: 195–209

    Article  PubMed  CAS  Google Scholar 

  28. Caruso I, Sarzi Puttini PC, Boccassini L, et al. Double blind study of dothiepin versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1987; 15: 154–9

    PubMed  CAS  Google Scholar 

  29. Gracious B, Wisner KL. Nortriptyline in chronic fatigue syndrome: a double-blind, placebo-controlled single case study. Biol Psychiatry 1991; 30: 405–8

    Article  PubMed  CAS  Google Scholar 

  30. Geller SA. Treatment of fibrositis with fluoxetine hydrochloride. Am J Med 1989; 87: 594–5

    Article  PubMed  CAS  Google Scholar 

  31. Finestone DH, Ober SK. Fluoxetine and fibromyalgia. JAMA 1990; 264: 2869–70

    Article  PubMed  CAS  Google Scholar 

  32. Goodnick PJ, Sandoval R. Treatment of chronic fatigue syndrome and related disorders: psychotropic agents. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington DC: American Psychiatric Press, 1993; 131–60

    Google Scholar 

  33. Pepper CM, Krupp LB, Friedberg F, et al. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiat Clin Neurosci 1993; 5: 200–5

    CAS  Google Scholar 

  34. Goodnick PJ. Bupropion in chronic fatigue syndrome [letter]. Am J Psychiatry 1990; 147: 1091

    PubMed  CAS  Google Scholar 

  35. Bakheit AMO, Behan PO, Dinan TG, et al. Possible upregulation of hypothalamic 5-hydroxy-tryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992; 304: 1010–2

    Article  PubMed  CAS  Google Scholar 

  36. Yunus MB, Dailey JW, Aldag JW, et al. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 1992; 19: 90–4

    PubMed  CAS  Google Scholar 

  37. Russell IJ, Vaeroy H, Javors M, et al. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35: 550–6

    Article  PubMed  CAS  Google Scholar 

  38. Demitrack M, Gold PW, Dale JK, et al. Plasma and cerebrospinal fluid monoamine metabolism in patients with CFS. Biol Psychiatry 1992; 32: 1065–77

    Article  PubMed  CAS  Google Scholar 

  39. Lloyd A, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double blind, placebo-controlled trial. Am J Med 1993; 94: 197–203

    Article  PubMed  CAS  Google Scholar 

  40. Butler S, Chalder T, Ron M, et al. Cognitive behaviour therapy in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1991; 54: 153–8

    Article  PubMed  CAS  Google Scholar 

  41. Goodnick PJ, Sandoval R. Treatment of chronic fatigue syndrome and related disorders: immunological approaches. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington DC: American Psychiatric Press, 1993; 109–30

    Google Scholar 

  42. DuBois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Res 1986; 1 Suppl.: S191–5

    Google Scholar 

  43. Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89: 554–60

    Article  PubMed  CAS  Google Scholar 

  44. Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990; 89: 561–8

    Article  PubMed  CAS  Google Scholar 

  45. Straus SE. Intravenous gammaglobulin treatment for the chronic fatigue syndrome. Am J Med 1990; 89: 551–3

    Article  PubMed  CAS  Google Scholar 

  46. Strayer D, Gillespie D, Peterson D, et al. Treatment of chronic fatigue immune dysfunction syndrome with Poly(I): Poly (C12U). Presented at the 31st ICAAC Meetings, Chicago, Illinois, October 1, 1990

    Google Scholar 

  47. Cotton P. Treatment proposed for chronic fatigue syndrome; research continues to compile data on disorder. JAMA 266; 2667

  48. Behan PO, Behan WMH. Essential fatty acids in the treatment of postviral fatigue syndrome. Omega-6 essential fatty acids: pathophysiology and roles in clinical medicine. London: Alan R. Liss, Inc, 1990; 275–82

    Google Scholar 

  49. Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome. N Eng J Med 1988; 319: 1692–8

    Article  CAS  Google Scholar 

  50. Kaslow JE, Rucker L, Onishi R. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Int Med 1989; 149: 2501–3

    Article  CAS  Google Scholar 

  51. Blondell-Hill E, Shafran D. Treatment of the chronic fatigue syndrome. Areview and practical guide. Drugs 1993; 46: 639–51

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Cambridge, Massachusetts, USA

    David S. Bell

  2. Pharmacy Department, The Cambridge Hospital, Cambridge, Massachusetts, USA

    Paul T. Concemi & Arifulla Khan

Authors
  1. David S. Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul T. Concemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arifulla Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bell, D.S., Concemi, P.T. & Khan, A. Chronic Fatigue Syndrome. CNS Drugs 1, 348–355 (1994). https://doi.org/10.2165/00023210-199401050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199401050-00005

Keywords

Search

Navigation